GT
Grace Therapeutics, Inc.
SEC filingPharmaceuticals · Princeton, NJ
Amount raised$10Msold at filing
Total offering$10M
Investors in the raise9count reported to the SEC
FiledAug 11, 2026first sale Aug 4, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Dr. R. Loch MacdonaldExecutive Officer
Edward George NeugeborenDirector
Prashant KohliExecutive Officer, Director
Robert J. DelAversanoExecutive Officer
A. Brian DavisDirector
Vimal KavuruDirector
S. George KottayilDirector
Amresh Loch KumarExecutive Officer
Executive officers, directors and promoters as listed on the Form D.